CME Group Inc (NASDAQ: CME) has a higher price-to-earnings ratio of 25.67x compared to its average ratio. CME has 36-month beta value of 0.56. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 10 as “hold,” and 0 as “sell.”
The public float for CME is 359.13M, and currently, short sellers hold a 1.25% ratio of that float. The average trading volume of CME on February 21, 2025 was 2.08M shares.
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME)’s stock price has decreased by -0.97 compared to its previous closing price of 250.75. However, the company has seen a -0.26% decrease in its stock price over the last five trading sessions. zacks.com reported 2025-02-20 that Here is how CME Group (CME) and Main Street Capital (MAIN) have performed compared to their sector so far this year.
CME’s Market Performance
CME Group Inc (CME) has experienced a -0.26% fall in stock performance for the past week, with a 6.92% rise in the past month, and a 12.97% rise in the past quarter. The volatility ratio for the week is 1.52%, and the volatility levels for the past 30 days are at 1.51% for CME. The simple moving average for the last 20 days is 2.75% for CME stock, with a simple moving average of 15.80% for the last 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Citigroup repeating the rating for CME by listing it as a “Neutral.” The predicted price for CME in the upcoming period, according to Citigroup is $250 based on the research report published on January 06, 2025 of the current year 2025.
Redburn Atlantic, on the other hand, stated in their research note that they expect to see CME reach a price target of $244. The rating they have provided for CME stocks is “Neutral” according to the report published on October 08th, 2024.
RBC Capital Mkts gave a rating of “Sector Perform” to CME, setting the target price at $235 in the report published on September 27th of the previous year.
CME Trading at 5.50% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.05% of loss for the given period.
Volatility was left at 1.51%, however, over the last 30 days, the volatility rate increased by 1.52%, as shares surge +6.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.93% upper at present.
During the last 5 trading sessions, CME fell by -0.26%, which changed the moving average for the period of 200-days by +19.68% in comparison to the 20-day moving average, which settled at $241.67. In addition, CME Group Inc saw 6.93% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from Vroman Ken, who sale 5,066 shares at the price of $250.00 back on Feb 13 ’25. After this action, Vroman Ken now owns 16,715 shares of CME Group Inc, valued at $1,266,500 using the latest closing price.
Winkler Julie, the Sr MD Chief Commercial Officer of CME Group Inc, sale 11,592 shares at $249.17 during a trade that took place back on Feb 13 ’25, which means that Winkler Julie is holding 21,885 shares at $2,888,379 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.64 for the present operating margin
- 0.86 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.11. Equity return is now at value 13.14, with 2.62 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.08. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 32.71.
Currently, EBITDA for the company is 4.61 billion with net debt to EBITDA at 0.12. When we switch over and look at the enterprise to sales, we see a ratio of 14.68. The receivables turnover for the company is 10.7for trailing twelve months and the total asset turnover is 0.04.
Conclusion
To put it simply, CME Group Inc (CME) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
